Institutional Ownership Pliant Therapeutics, Inc. (PLRX)
This table provides information about the institutional ownership of Pliant Therapeutics, Inc. (PLRX). We have compiled data on the 172 institutions that hold shares in the stock, with a total of 64.7 Million shares, which have been reported (via 13F filing form) to have a value of $95.1 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
628,281
shares
|
$923,573
0.0% of portfolio
|
Q4 2024
Added 172.8%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
555,600
shares
|
$816,732
0.0% of portfolio
|
Q4 2024
Added 10.67%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
547,297
shares
|
$804,526
0.0% of portfolio
|
Q4 2024
Added 19.98%
|
|
|
Checkpoint Capital L.P.
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
535,494
shares
|
$787,176
3.59% of portfolio
|
Q4 2024
Added 40.92%
|
|
|
Bessemer Group Inc
Woodbridge, NJ |
Feb 13, 2025 Q4 2024 |
532,174
shares
|
$782,295
0.01% of portfolio
|
Q3 2024
Added 0.02%
|
|
|
Granahan Investment Management, LLC
Waltham, MA |
Feb 14, 2025 Q4 2024 |
527,147
shares
|
$774,906
0.33% of portfolio
|
Q4 2024
Reduced 28.6%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
459,384
shares
|
$675,294
0.0% of portfolio
|
Q4 2024
Added 0.6%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
446,700
shares
|
$656,649
0.0% of portfolio
|
Q4 2024
Added 28.58%
|
|
|
Fernwood Investment Management, LLC
Quincy, MA |
Feb 13, 2025 Q4 2024 |
425,424
shares
|
$625,373
1.98% of portfolio
|
Q4 2024
Reduced 17.09%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
404,796
shares
|
$595,050
0.21% of portfolio
|
Q4 2024
Added 5.14%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
401,689
shares
|
$590,482
0.0% of portfolio
|
Q4 2024
Added 1045.91%
|
|
|
Axa S.A.
Paris, I0 |
Feb 14, 2025 Q4 2024 |
346,941
shares
|
$510,003
0.01% of portfolio
|
Q2 2024
Added 0.13%
|
|
|
Trv Gp Iii, LLC
Boston, MA |
Feb 14, 2024 Q4 2023 |
339,160
shares
|
$498,565
100.0% of portfolio
|
Q2 2023
Reduced 81.56%
|
|
|
Integral Health Asset Management, LLC
|
Feb 14, 2025 Q4 2024 |
300,000
shares
|
$441,000
0.35% of portfolio
|
Q3 2024
New holding
|
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Feb 14, 2025 Q4 2024 |
297,362
shares
|
$437,122
0.81% of portfolio
|
Q3 2024
Added 15.01%
|
|
|
Mass General Brigham, Inc
|
Oct 16, 2024 Q3 2024 |
288,690
shares
|
$424,374
7.42% of portfolio
|
Q1 2024
New holding
|
|
|
Arrow Mark Colorado Holdings LLC
Denver, CO |
Feb 14, 2025 Q4 2024 |
281,189
shares
|
$413,347
0.06% of portfolio
|
Q2 2023
New holding
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
206,947
shares
|
$304,212
0.0% of portfolio
|
Q4 2024
Reduced 38.31%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
197,251
shares
|
$289,958
0.0% of portfolio
|
Q4 2024
Added 300.82%
|
|
|
Jane Street Group, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
182,015
shares
|
$267,562
0.0% of portfolio
|
Q4 2024
Reduced 2.52%
|
|
|
Rice Hall James & Associates, LLC
|
Jan 31, 2025 Q4 2024 |
160,522
shares
|
$235,967
0.13% of portfolio
|
Q4 2024
Added 2.1%
|
|
|
Caption Management, LLC
Oklahoma City, OK |
Feb 14, 2025 Q4 2024 |
142,404
shares
|
$209,333
0.02% of portfolio
|
Q4 2024
New holding
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
139,574
shares
|
$205,173
0.0% of portfolio
|
Q4 2024
Added 18.35%
|
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Feb 14, 2025 Q4 2024 |
135,700
shares
|
$199,479
0.0% of portfolio
|
Q4 2024
Reduced 14.01%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Feb 13, 2025 Q4 2024 |
134,798
shares
|
$198,153
0.35% of portfolio
|
Q4 2024
Reduced 45.23%
|